INTELLIGENT BIO SOLUTIONS INC. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
INTELLIGENT BIO SOLUTIONS INC. (INBS) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $5.70 million as of 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2026-08-19
- 2026-06-30: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $5.70M.
- 2025-06-30: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $5.21M.
- 2024-06-30: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $4.18M.
- 2023-06-30: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $3.91M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic as first filed |
|---|---|---|
| 2026-06-30 | $5.70M 10-K · filed 2026-08-19 | |
| 2025-06-30 | $5.21M 10-K · filed 2026-08-19 | |
| 2024-06-30 | $4.18M 10-K · filed 2025-08-15 | |
| 2023-06-30 | $3.91M 10-K · filed 2024-09-18 | |
| 2022-06-30 | $4.32M 10-K · filed 2023-08-23 | |
| 2021-06-30 | $4.74M 10-K · filed 2022-09-22 | $4.57M 10-K · filed 2021-09-16 |
| 2020-06-30 | $3.51M 10-K · filed 2021-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |